Dongin (Donoven) Kim, Ph.D.
Assistant Professor
Pharmaceutical Sciences
Phone (405) 271-6593 x 47473
Office College of Pharmacy, CPB 317
Email dongin-kim@ouhsc.edu
Publications & Presentations
- 26. Kang C, Kim D. Nanoconfinement-mediated cancer theranostics. Archives of pharmacal research. 2020; 43 : 110-117
27. Yoo D, Jung E, Noh J, Hyun H, Seon S, Hong S, Kim D, Lee D. Glutathione-Depleting Pro-Oxidant as a Selective Anticancer Therapeutic Agent. ACS omega. 2019; 4 : 10070-10077
28. Ash G I, Kim D, Choudhury M. Promises of Nanotherapeutics in Obesity. Trends in endocrinology and metabolism: TEM. 2019; 30 : 369-383
29. Whang C H, Yoo E, Hur S K, Kim K S, Kim D, Jo S. A highly GSH-sensitive SN-38 prodrug with an "OFF-to-ON" fluorescence switch as a bifunctional anticancer agent. Chemical communications (Cambridge, England). 2018; 54 : 9031-9034
30. Wang J, Lee J S, Kim D, Zhu L. Exploration of Zinc Oxide Nanoparticles as a Multitarget and Multifunctional Anticancer Nanomedicine. ACS applied materials & interfaces. 2017; 9 : 39971-39984
Grants
- 11. Translational Studies on Extracellular Vesicles in Ovarian Cancer. Non-federal. Start Date: 2022. End Date: 2022.
12. Developing RNAi-based control method targeting Mormon cricket. Misc Federal. Start Date: 2020. End Date: 2021.
Awards and Honors
no results
Education
- 1. Degree: Ph D. University of Utah. Date: 2009.
2. Degree: MS. University of Florida. Date: 2002.
3. Degree: BS. Ajou University. Date: 1999.
Administrative Assignments
no results